Bisphosphonates and osteonecrosis of the jaw: Innocent association or significant risk?

John J. Carey, Leena Palomo

Research output: Contribution to journalReview articlepeer-review

Abstract

Published case series and systematic reviews have documented an association between bisphosphonates and osteonecrosis of the jaw. However, a cause-and-effect relationship has not been established, and most of the reported cases have been in patients with cancer who were receiving much higher doses than those used to treat osteoporosis or Paget disease of bone. The risk, if any, to patients with these latter conditions receiving these drugs appears to be very small.

Original languageEnglish (US)
Pages (from-to)871-878
Number of pages8
JournalCleveland Clinic Journal of Medicine
Volume75
Issue number12
DOIs
StatePublished - 2008

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Bisphosphonates and osteonecrosis of the jaw: Innocent association or significant risk?'. Together they form a unique fingerprint.

Cite this